世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子組換えヒトインターロイキンの世界市場インサイト、2030年までの予測


Global Recombinant Human Interleukin Market Insights, Forecast to 2030

インターロイキン(IL)は、白血球(白血球)によって初めて発現が確認されたサイトカイン(分泌タンパク質およびシグナル分子)群である。ILは、構造上の特徴から4つの主要なグループに分けられる。しかし、それ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年8月23日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

インターロイキン(IL)は、白血球(白血球)によって初めて発現が確認されたサイトカイン(分泌タンパク質およびシグナル分子)群である。ILは、構造上の特徴から4つの主要なグループに分けられる。しかし、それらのアミノ酸配列の類似性はかなり弱い(通常、同一性は15-25%)。ヒトゲノムには50以上のインターロイキンおよび関連タンパク質がコードされている。

組換えヒトインターロイキンの世界市場は、2024年の100万米ドルから2030年には100万米ドルへと、予測期間中の年平均成長率(CAGR)%で拡大すると予測されている。
遺伝子組換えヒトインターロイキンの米国とカナダ市場は、2025年から2030年の予測期間中に年平均成長率(CAGR)%で、2024年の百万米ドルから2030年には百万米ドルに達すると予測されています。
遺伝子組換えヒトインターロイキンの中国市場は、2024年の100万ドルから2025年から2030年の予測期間中に年平均成長率%で増加し、2030年には100万ドルに達すると推定される。
遺伝子組換え型ヒトインターロイキンの欧州市場は、2025年から2030年の予測期間において年平均成長率%で、2024年の百万ドルから2030年には百万ドルに達すると推定される。
遺伝子組み換えヒトインターロイキンの世界の主要メーカーは、Qilu Pharmaceutical、Hangzhou Jiuyuan、Merck and Co、Novartis Pharma、Abnova、Advanced Biotechnologies Inc、Cayman Chemical、Cell Signaling Technology、Thermo Fisherなどである。2023年、世界の上位5社の売上高シェアは約 %であった。

レポートの対象
本レポートでは、遺伝子組換えヒトインターロイキンの世界市場概要、売上高、価格を紹介します。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
遺伝子組換えヒトインターロイキンの主要生産者を調査し、主要地域・国の売上高も掲載しています。遺伝子組換え型ヒトインターロイキンの今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、組み換えヒトインターロイキンの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界の遺伝子組換え型ヒトインターロイキン市場における主要な利害関係者の特定、および最近の動向とセグメント別の収益に基づく競争環境と市場ポジショニングの分析。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。遺伝子組換えヒトインターロイキンの売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。

市場区分
企業別
斉魯薬業
杭州久遠
メルク・アンド・カンパニー
ノバルティスファーマ
アブノバ
アドバンスト・バイオテクノロジーズ
ケイマンケミカル
セル・シグナル・テクノロジー
サーモフィッシャー
タイプ別
IL-1
IL-2
IL-10
その他
用途別セグメント
医薬品
科学研究
地域別セグメント
米国・カナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 組換え型ヒトインターロイキンの世界、地域レベル、国レベルでの販売(消費)、収益各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章:遺伝子組換えヒトインターロイキンメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性などを網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、アプリケーション別に様々な市場セグメントの分析を提供します。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、組換え型ヒトインターロイキンの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Recombinant Human Interleukin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Interleukin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IL-1
1.2.3 IL-2
1.2.4 IL-10
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Interleukin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medication
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Interleukin Revenue by Region
2.2.1 Global Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Interleukin Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Interleukin Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Interleukin Sales by Region
2.4.1 Global Recombinant Human Interleukin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Interleukin Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Interleukin Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Interleukin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Interleukin Sales by Manufacturers
3.1.1 Global Recombinant Human Interleukin Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Interleukin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Interleukin in 2023
3.2 Global Recombinant Human Interleukin Revenue by Manufacturers
3.2.1 Global Recombinant Human Interleukin Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Interleukin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Interleukin Revenue in 2023
3.3 Global Key Players of Recombinant Human Interleukin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Interleukin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Interleukin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Interleukin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Interleukin Sales by Type
4.1.1 Global Recombinant Human Interleukin Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Interleukin Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Interleukin Revenue by Type
4.2.1 Global Recombinant Human Interleukin Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Interleukin Price by Type
4.3.1 Global Recombinant Human Interleukin Price by Type (2019-2024)
4.3.2 Global Recombinant Human Interleukin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Interleukin Sales by Application
5.1.1 Global Recombinant Human Interleukin Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Interleukin Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Interleukin Revenue by Application
5.2.1 Global Recombinant Human Interleukin Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Interleukin Price by Application
5.3.1 Global Recombinant Human Interleukin Price by Application (2019-2024)
5.3.2 Global Recombinant Human Interleukin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Interleukin Market Size by Type
6.1.1 US & Canada Recombinant Human Interleukin Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Interleukin Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Interleukin Market Size by Application
6.2.1 US & Canada Recombinant Human Interleukin Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Interleukin Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Interleukin Market Size by Country
6.3.1 US & Canada Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Interleukin Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Interleukin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Interleukin Market Size by Type
7.1.1 Europe Recombinant Human Interleukin Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Interleukin Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Interleukin Market Size by Application
7.2.1 Europe Recombinant Human Interleukin Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Interleukin Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Interleukin Market Size by Country
7.3.1 Europe Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Interleukin Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Interleukin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Interleukin Market Size
8.1.1 China Recombinant Human Interleukin Sales (2019-2030)
8.1.2 China Recombinant Human Interleukin Revenue (2019-2030)
8.2 China Recombinant Human Interleukin Market Size by Application
8.2.1 China Recombinant Human Interleukin Sales by Application (2019-2030)
8.2.2 China Recombinant Human Interleukin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Interleukin Market Size by Type
9.1.1 Asia Recombinant Human Interleukin Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Interleukin Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Interleukin Market Size by Application
9.2.1 Asia Recombinant Human Interleukin Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Interleukin Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Interleukin Sales by Region
9.3.1 Asia Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Interleukin Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Interleukin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Overview
11.1.3 Qilu Pharmaceutical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Qilu Pharmaceutical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qilu Pharmaceutical Recent Developments
11.2 Hangzhou Jiuyuan
11.2.1 Hangzhou Jiuyuan Company Information
11.2.2 Hangzhou Jiuyuan Overview
11.2.3 Hangzhou Jiuyuan Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Hangzhou Jiuyuan Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hangzhou Jiuyuan Recent Developments
11.3 Merck and Co
11.3.1 Merck and Co Company Information
11.3.2 Merck and Co Overview
11.3.3 Merck and Co Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck and Co Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck and Co Recent Developments
11.4 Novartis Pharma
11.4.1 Novartis Pharma Company Information
11.4.2 Novartis Pharma Overview
11.4.3 Novartis Pharma Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis Pharma Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Pharma Recent Developments
11.5 Abnova
11.5.1 Abnova Company Information
11.5.2 Abnova Overview
11.5.3 Abnova Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Abnova Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abnova Recent Developments
11.6 Advanced Biotechnologies Inc
11.6.1 Advanced Biotechnologies Inc Company Information
11.6.2 Advanced Biotechnologies Inc Overview
11.6.3 Advanced Biotechnologies Inc Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Advanced Biotechnologies Inc Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Advanced Biotechnologies Inc Recent Developments
11.7 Cayman Chemical
11.7.1 Cayman Chemical Company Information
11.7.2 Cayman Chemical Overview
11.7.3 Cayman Chemical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Cayman Chemical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cayman Chemical Recent Developments
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Information
11.8.2 Cell Signaling Technology Overview
11.8.3 Cell Signaling Technology Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cell Signaling Technology Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cell Signaling Technology Recent Developments
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Information
11.9.2 Thermo Fisher Overview
11.9.3 Thermo Fisher Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Thermo Fisher Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Thermo Fisher Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Interleukin Industry Chain Analysis
12.2 Recombinant Human Interleukin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Interleukin Production Mode & Process
12.4 Recombinant Human Interleukin Sales and Marketing
12.4.1 Recombinant Human Interleukin Sales Channels
12.4.2 Recombinant Human Interleukin Distributors
12.5 Recombinant Human Interleukin Customers
13 Market Dynamics
13.1 Recombinant Human Interleukin Industry Trends
13.2 Recombinant Human Interleukin Market Drivers
13.3 Recombinant Human Interleukin Market Challenges
13.4 Recombinant Human Interleukin Market Restraints
14 Key Findings in The Global Recombinant Human Interleukin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Interleukins (ILs) are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes). ILs can be divided into four major groups based on distinguishing structural features. However, their amino acid sequence similarity is rather weak (typically 15–25% identity). The human genome encodes more than 50 interleukins and related proteins.

The global Recombinant Human Interleukin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Recombinant Human Interleukin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Recombinant Human Interleukin include Qilu Pharmaceutical, Hangzhou Jiuyuan, Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology and Thermo Fisher, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Recombinant Human Interleukin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Interleukin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Interleukin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Interleukin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Interleukin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Interleukin sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation
By Company
Qilu Pharmaceutical
Hangzhou Jiuyuan
Merck and Co
Novartis Pharma
Abnova
Advanced Biotechnologies Inc
Cayman Chemical
Cell Signaling Technology
Thermo Fisher
Segment by Type
IL-1
IL-2
IL-10
Others
Segment by Application
Medication
Scientific Research
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Interleukin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Interleukin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Interleukin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Recombinant Human Interleukin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Interleukin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IL-1
1.2.3 IL-2
1.2.4 IL-10
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Interleukin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medication
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Interleukin Revenue by Region
2.2.1 Global Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Interleukin Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Interleukin Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Interleukin Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Interleukin Sales by Region
2.4.1 Global Recombinant Human Interleukin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Interleukin Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Interleukin Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Interleukin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Interleukin Sales by Manufacturers
3.1.1 Global Recombinant Human Interleukin Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Interleukin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Interleukin in 2023
3.2 Global Recombinant Human Interleukin Revenue by Manufacturers
3.2.1 Global Recombinant Human Interleukin Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Interleukin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Interleukin Revenue in 2023
3.3 Global Key Players of Recombinant Human Interleukin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Interleukin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Interleukin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Interleukin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Interleukin Sales by Type
4.1.1 Global Recombinant Human Interleukin Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Interleukin Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Interleukin Revenue by Type
4.2.1 Global Recombinant Human Interleukin Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Interleukin Price by Type
4.3.1 Global Recombinant Human Interleukin Price by Type (2019-2024)
4.3.2 Global Recombinant Human Interleukin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Interleukin Sales by Application
5.1.1 Global Recombinant Human Interleukin Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Interleukin Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Interleukin Revenue by Application
5.2.1 Global Recombinant Human Interleukin Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Interleukin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Interleukin Price by Application
5.3.1 Global Recombinant Human Interleukin Price by Application (2019-2024)
5.3.2 Global Recombinant Human Interleukin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Interleukin Market Size by Type
6.1.1 US & Canada Recombinant Human Interleukin Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Interleukin Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Interleukin Market Size by Application
6.2.1 US & Canada Recombinant Human Interleukin Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Interleukin Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Interleukin Market Size by Country
6.3.1 US & Canada Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Interleukin Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Interleukin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Interleukin Market Size by Type
7.1.1 Europe Recombinant Human Interleukin Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Interleukin Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Interleukin Market Size by Application
7.2.1 Europe Recombinant Human Interleukin Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Interleukin Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Interleukin Market Size by Country
7.3.1 Europe Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Interleukin Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Interleukin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Interleukin Market Size
8.1.1 China Recombinant Human Interleukin Sales (2019-2030)
8.1.2 China Recombinant Human Interleukin Revenue (2019-2030)
8.2 China Recombinant Human Interleukin Market Size by Application
8.2.1 China Recombinant Human Interleukin Sales by Application (2019-2030)
8.2.2 China Recombinant Human Interleukin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Interleukin Market Size by Type
9.1.1 Asia Recombinant Human Interleukin Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Interleukin Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Interleukin Market Size by Application
9.2.1 Asia Recombinant Human Interleukin Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Interleukin Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Interleukin Sales by Region
9.3.1 Asia Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Interleukin Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Interleukin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Interleukin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Interleukin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Interleukin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Overview
11.1.3 Qilu Pharmaceutical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Qilu Pharmaceutical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qilu Pharmaceutical Recent Developments
11.2 Hangzhou Jiuyuan
11.2.1 Hangzhou Jiuyuan Company Information
11.2.2 Hangzhou Jiuyuan Overview
11.2.3 Hangzhou Jiuyuan Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Hangzhou Jiuyuan Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hangzhou Jiuyuan Recent Developments
11.3 Merck and Co
11.3.1 Merck and Co Company Information
11.3.2 Merck and Co Overview
11.3.3 Merck and Co Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck and Co Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck and Co Recent Developments
11.4 Novartis Pharma
11.4.1 Novartis Pharma Company Information
11.4.2 Novartis Pharma Overview
11.4.3 Novartis Pharma Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis Pharma Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Pharma Recent Developments
11.5 Abnova
11.5.1 Abnova Company Information
11.5.2 Abnova Overview
11.5.3 Abnova Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Abnova Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abnova Recent Developments
11.6 Advanced Biotechnologies Inc
11.6.1 Advanced Biotechnologies Inc Company Information
11.6.2 Advanced Biotechnologies Inc Overview
11.6.3 Advanced Biotechnologies Inc Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Advanced Biotechnologies Inc Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Advanced Biotechnologies Inc Recent Developments
11.7 Cayman Chemical
11.7.1 Cayman Chemical Company Information
11.7.2 Cayman Chemical Overview
11.7.3 Cayman Chemical Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Cayman Chemical Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cayman Chemical Recent Developments
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Information
11.8.2 Cell Signaling Technology Overview
11.8.3 Cell Signaling Technology Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Cell Signaling Technology Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cell Signaling Technology Recent Developments
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Information
11.9.2 Thermo Fisher Overview
11.9.3 Thermo Fisher Recombinant Human Interleukin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Thermo Fisher Recombinant Human Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Thermo Fisher Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Interleukin Industry Chain Analysis
12.2 Recombinant Human Interleukin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Interleukin Production Mode & Process
12.4 Recombinant Human Interleukin Sales and Marketing
12.4.1 Recombinant Human Interleukin Sales Channels
12.4.2 Recombinant Human Interleukin Distributors
12.5 Recombinant Human Interleukin Customers
13 Market Dynamics
13.1 Recombinant Human Interleukin Industry Trends
13.2 Recombinant Human Interleukin Market Drivers
13.3 Recombinant Human Interleukin Market Challenges
13.4 Recombinant Human Interleukin Market Restraints
14 Key Findings in The Global Recombinant Human Interleukin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る